US equities |
SPCX $168.37 ▲+5.92% NVDA $237.18 ▲+1.38% MU $1,066.48 ▼-0.78% TSLA $378.95 ▲+2.26% MSFT $525.68 ▲+1.57% SNDK $1,713.61 ▼-0.37% INTC $117.23 ▼-1.76% META $743.39 ▲+2.10%
FinancialContent

Articles published by Zoetis Inc.

< Previous 1 2 3 4 5 Next >
News headline image
Zoetis to Host Innovation Webcast
From Zoetis Inc.
Via Business Wire
Tickers ZTS
News headline image
Zoetis Announces Third Quarter 2025 Results
From Zoetis Inc.
Via Business Wire
Tickers ZTS
News headline image
Zoetis Announces Retirement of Rob Polzer at the End of 2025 and the Appointment of Kevin Esch as President of Research & Development for World Leader in Animal Health Beginning in 2026
From Zoetis Inc.
Via Business Wire
Tickers ZTS
News headline image
Zoetis Receives European Commission Marketing Authorization for Portela® (relfovetmab) to Alleviate Pain Associated with Osteoarthritis in Cats
From Zoetis Inc.
Via Business Wire
Tickers ZTS
News headline image
Zoetis Appoints Stephanie Tilenius to its Board of Directors
From Zoetis Inc.
Via Business Wire
Tickers ZTS
News headline image
Zoetis Announces Health Canada Approval of Lenivia® (izenivetmab injection) for Alleviation of Osteoarthritis (OA) Pain in Dogs
From Zoetis Inc.
Via Business Wire
Tickers ZTS
News headline image
Zoetis Receives Positive Opinion from CVMP for Lenivia® (izenivetmab) to Reduce Pain Associated with Osteoarthritis (OA) in Dogs
From Zoetis Inc.
Via Business Wire
Tickers ZTS
News headline image
Zoetis Declares Fourth Quarter 2025 Dividend
From Zoetis Inc.
Via Business Wire
Tickers ZTS
News headline image
Zoetis Receives Conditional Approval for Dectomax®-CA1 Injectable for the Prevention and Treatment of New World Screwworm Myiasis in Cattle
From Zoetis Inc.
Via Business Wire
Tickers ZTS
News headline image
Zoetis to Host Webcast and Conference Call on Third Quarter 2025 Financial Results
From Zoetis Inc.
Via Business Wire
Tickers ZTS
News headline image
Zoetis Receives Positive Opinion from CVMP for Portela® (relfovetmab) to Alleviate Pain Associated with Osteoarthritis in Cats
From Zoetis Inc.
Via Business Wire
Tickers ZTS
News headline image
Zoetis to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference
From Zoetis Inc.
Via Business Wire
Tickers ZTS
News headline image
Zoetis Announces Pricing of $1.85 Billion of Senior Notes
From Zoetis Inc.
Via Business Wire
Tickers ZTS
News headline image
Zoetis Announces Second Quarter 2025 Results, Raises Full Year 2025 Outlook
From Zoetis Inc.
Via Business Wire
Tickers ZTS
News headline image
Zoetis to Host Webcast and Conference Call on Second Quarter 2025 Financial Results
From Zoetis Inc.
Via Business Wire
Tickers ZTS
News headline image
Zoetis Releases 2024 Sustainability Progress Update
From Zoetis Inc.
Via Business Wire
Tickers ZTS
News headline image
Dr. Mark Stetter Elected to Zoetis Board of Directors
From Zoetis Inc.
Via Business Wire
Tickers ZTS
News headline image
Zoetis Declares Third Quarter 2025 Dividend
From Zoetis Inc.
Via Business Wire
Tickers ZTS
News headline image
Zoetis to Participate in Upcoming Investor Conferences
From Zoetis Inc.
Via Business Wire
Tickers ZTS
News headline image
Zoetis Announces First Quarter 2025 Results
From Zoetis Inc.
Via Business Wire
Tickers ZTS
News headline image
Zoetis to Host Webcast and Conference Call on First Quarter 2025 Financial Results
From Zoetis Inc.
Via Business Wire
Tickers ZTS
News headline image
Zoetis to Participate in Upcoming Investor Conferences
From Zoetis Inc.
Via Business Wire
Tickers ZTS
News headline image
Zoetis Receives Conditional License from USDA for Avian Influenza Vaccine, H5N2 Subtype, Killed Virus
From Zoetis Inc.
Via Business Wire
Tickers ZTS
News headline image
Zoetis Reports Fourth Quarter and Full Year 2024 Results
From Zoetis Inc.
Via Business Wire
Tickers ZTS
News headline image
Zoetis Declares Second Quarter 2025 Dividend
From Zoetis Inc.
Via Business Wire
Tickers ZTS
News headline image
Zoetis Announces U.S. Label Update for Librela® (bedinvetmab injection), a Treatment to Control Canine Osteoarthritis (OA) Pain
From Zoetis Inc.
Via Business Wire
Tickers ZTS
News headline image
Zoetis to Host Webcast and Conference Call on Fourth Quarter and Full Year 2024 Financial Results
From Zoetis Inc.
Via Business Wire
Tickers ZTS
News headline image
Zoetis Declares First Quarter 2025 Dividend; Board Approves 16% Payment Increase
From Zoetis Inc.
Via Business Wire
Tickers ZTS
News headline image
Zoetis to Participate in the Piper Sandler 36th Annual Healthcare Conference
From Zoetis Inc.
Via Business Wire
Tickers ZTS
News headline image
Zoetis Appoints Jamie Brannan to Newly Created Chief Commercial Officer Role
From Zoetis Inc.
Via Business Wire
Tickers ZTS
< Previous 1 2 3 4 5 Next >